Brandon May

Most Recent Articles by Brandon May

Adjunctive Dapagliflozin Effectively Improves Glycemic Control in T1D

Adjunctive Dapagliflozin Effectively Improves Glycemic Control in T1D

By

Dapagliflozin improves glycemic control in patients with inadequately controlled type 1 diabetes currently taking insulin.

Pancreatic Exocrine Dysfunction Occurs After Islet Autoimmunity in T1D

Pancreatic Exocrine Dysfunction Occurs After Islet Autoimmunity in T1D

By

A new study suggests that pancreatic exocrine dysfunction develops after initiation of islet cell autoimmunity, suggesting that exocrine dysfunction is related to diabetes disease pathogenesis itself.

High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D

High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D

By

Levels of high sensitivity C-reactive protein may help risk stratify those patients with T2D and recent acute coronary syndrome at further risk of recurrent cardiovascular events.

Family-Based Therapy Feasible for Overweight, Obese Children and Their Parents

Family-Based Therapy Feasible for Overweight, Obese Children and Their Parents

By

Higher-dose and specialized treatment content designed to help families maintain weight-control behaviors following family-based behavioral weight loss treatment enhances weight outcomes.

Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients

Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients

By

The association between statin use and diabetes risk in a cohort of overweight and obese patients was examined.

More Articles by Brandon May

Sign Up for Free e-Newsletters

CME Focus